Recognition of DHN-melanin by a C-type lectin receptor is required for immunity to Aspergillus by Stappers, Mark H. T. et al.
3 8 2  |  N A T U R E  |  V O L  5 5 5  |  1 5  m A R c h  2 0 1 8
LETTER
doi:10.1038/nature25974
Recognition of DHN-melanin by a C-type lectin 
receptor is required for immunity to Aspergillus 
mark h. T. Stappers1*, Alexandra E. clark1*, Vishukumar Aimanianda2*, Stefan Bidula1, Delyth m. Reid1,  
Patawee Asamaphan1, Sarah E. hardison1, Ivy m. Dambuza1, Isabel Valsecchi2, Bernhard Kerscher1, Anthony Plato1, 
carol A. Wallace1, Raif Yuecel3, Betty hebecker1, maria da Glória Teixeira Sousa1, cristina cunha4,5, Yan Liu6,   Ten Feizi6, 
Axel A. Brakhage7, Kyung J. Kwon-chung8, Neil A. R. Gow1, matteo Zanda9, monica Piras9, chiara Zanato9, martin Jaeger10, 
mihai G. Netea10, Frank L. van de Veerdonk10, João F. Lacerda11,12, António campos Jr13, Agostinho carvalho4,5, 
Janet A. Willment1, Jean-Paul Latgé2† & Gordon D. Brown1
Resistance to infection is critically dependent on the ability of 
pattern recognition receptors to recognize microbial invasion 
and induce protective immune responses. One such family of 
receptors are the C-type lectins, which are central to antifungal 
immunity1. These receptors activate key effector mechanisms upon 
recognition of conserved fungal cell-wall carbohydrates. However, 
several other immunologically active fungal ligands have been 
described; these include melanin2,3, for which the mechanism of 
recognition is hitherto undefined. Here we identify a C-type lectin 
receptor, melanin-sensing C-type lectin receptor (MelLec), that 
has an essential role in antifungal immunity through recognition 
of the naphthalene-diol unit of 1,8-dihydroxynaphthalene 
(DHN)-melanin. MelLec recognizes melanin in conidial spores 
of Aspergillus fumigatus as well as in other DHN-melanized fungi. 
MelLec is ubiquitously expressed by CD31+ endothelial cells in 
mice, and is also expressed by a sub-population of these cells that 
co-express epithelial cell adhesion molecule and are detected only 
in the lung and the liver. In mouse models, MelLec was required 
for protection against disseminated infection with A. fumigatus. In 
humans, MelLec is also expressed by myeloid cells, and we identified 
a single nucleotide polymorphism of this receptor that negatively 
affected myeloid inflammatory responses and significantly 
increased the susceptibility of stem-cell transplant recipients to 
disseminated Aspergillus infections. MelLec therefore recognizes 
an immunologically active component commonly found on fungi 
and has an essential role in protective antifungal immunity in both 
mice and humans.
C-type lectin receptors (CLRs) involved in antifungal immu-
nity belong primarily to the Dectin-1 (also known as CLEC7A) and 
Dectin-2 (also known as CLEC4N) clusters of receptors located near 
the natural killer gene complex1. To identify new CLRs within these 
clusters that recognize fungi, we generated soluble protein chimaeras 
consisting of the C-type lectin-like domain of murine receptors fused 
to the Fc region of human immunoglobulin G14 (Fc-MelLec, Extended 
Data Fig. 1a) and used these chimaeric proteins as probes to screen for 
the recognition of fungi by flow cytometry. Using this approach, we 
identified the C-type lectin-like domain of MelLec (CLEC1A (ref. 5), 
Extended Data Fig. 1b), which bound A. fumigatus conidia (Fig. 1a). 
MelLec did not recognize other commonly occurring fungi, such as 
Candida albicans yeast and filamentous cells, or Saccharomyces cerevi-
siae yeasts, but did recognize other  melanized fungal species, includ-
ing Fonsecaea pedrosoi and Cladosporium  cladosporioides (Fig. 1b, 
Extended Data Fig. 1c, e). This indicated that the ligand recognized 
by MelLec was not ubiquitously found in all fungi, unlike the ligands 
of other antifungal CLRs such as Dectin-1 (ref. 1). Notably, the abil-
ity of MelLec to recognize A. fumigatus was restricted to conidia, and 
recognition was rapidly lost after conidial swelling, germination and 
hyphal growth (Fig. 1a, c and Extended Data Fig. 2d). The binding 
to conidia was visualized by immunofluorescence microscopy, which 
revealed a punctate staining pattern suggestive of a restricted distri-
bution of the moiety recognized by MelLec on these spores (Fig. 1c). 
Conidia are covered by a hydrophobic rodlet layer, which masks under-
lying components of the cell wall from immune recognition6. The 
removal of this rodlet layer with sodium hydroxide6 led to increased and 
uniform binding of MelLec over the entire conidial surface (Fig. 1d). 
Indeed, uniform staining was obtained with rodlet-deficient conidia 
(ΔrodA), confirming that the ligand of MelLec is partially masked by 
the surface hydrophobin layer (Fig. 1e). Recognition of A. fumigatus 
conidia by MelLec was also demonstrated in a cellular context using 
MelLec reporter cells4 (Extended Data Fig. 1f).
All characterized CLRs that are involved in fungal sensing act by 
recognition of carbohydrate components of the fungal cell wall1. 
Consistent with this possibility, MelLec ligand(s) were detected by 
enzyme-linked immunosorbent assay (ELISA) primarily in the alka-
li-insoluble fraction of the A. fumigatus conidial cell wall, the primary 
constituents of which are carbohydrates (β-glucan, chitin and galac-
tomannan) and melanin7 (Fig. 2a). The Fc-MelLec fusion protein was 
used as a probe to screen a neoglycolipid-based glycan microarray con-
taining almost 500 structures, including oligosaccharides derived from 
glucans and chitin that are found in fungi8 (Supplementary Table 1). 
This screen did not reveal any carbohydrate ligands for MelLec;  ligands 
were detected, however, for the C-type lectin langerin, which was 
used as a control (Extended Data Fig. 2). We then used Fc-MelLec 
to screen A. fumigatus conidia that were mutated in various relevant 
cell-wall biosynthetic pathways, using flow cytometry and immuno-
fluorescence microscopy. This revealed that Fc-MelLec failed to detect 
ΔpksP mutant conidia, which are deficient in the ability to synthesize 
heptaketide naphthopyrone (YWA1), the first intermediate of the 
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DHN-melanin biosynthetic pathway2,9 (Fig. 2b and Extended Data 
Fig. 3a). We also confirmed loss of the MelLec ligand on ΔrodAΔpksP 
double mutant conidia10—which lack both melanin and the hydro-
phobin layer—using flow cytometry, immunofluorescence microscopy 
and our MelLec reporter cells (Extended Data Figs 1f and 3b, c). Loss 
of pksP did not affect conidial recognition by Fc-Dectin-1 (Extended 
Data Fig. 3c, d). Moreover, we demonstrated a direct interaction of 
MelLec with A. fumigatus melanin ghosts (Extended Data Fig. 3e). 
MelLec recognized specifically DHN-melanin, as this receptor did 
not detect melanin synthesized by other pathways, such as those used 
by Cryptococcus neoformans, and mammalian B16 melanoma cells11 
(Extended Data Fig. 3f). In addition to A. fumigatus, we showed that 
MelLec recognized other pigmented fungi that produce DHN-melanin, 
including F. pedrosoi and C. cladosporioides12 (Fig. 1b and Extended 
Data Fig. 1e).
Although its tertiary structure is unresolved11, the biosynthetic 
pathway of DHN-melanin is well characterized in A. fumigatus3. To 
determine at which stage MelLec ligand(s) are synthesized in the 
pathway, we screened mutants of A. fumigatus that were deficient 
in the enzymes required to catalyse each step, using Fc-MelLec and 
immuno fluorescence microscopy, or ELISA. We confirmed that MelLec 
recognition was lost in ΔpksP conidia; however, MelLec recognition 
was unaffected in mutants deficient in the enzymes required for all 
other stages of the DHN-melanin biosynthetic pathway (Fig. 2c and 
Extended Data Fig. 4a). Using a pre-adsorption assay, we showed that 
the recognition of wild-type conidia could be inhibited by pretreating 
Fc-MelLec with Δayg1 ghosts (defective in the second biosynthetic 
step, in which MelLec ligands are still present), but not ghosts of ΔpksP 
(the first biosynthetic step, which lacks MelLec ligands; Extended 
Data Fig. 4b). We purified YWA1 from Δayg1 conidia13 and demon-
strated that pretreatment with this compound inhibited the ability 
of Fc-MelLec, but not the ability of Fc-Dectin-1, to detect ΔrodA 
conidia or sodium hydroxide-treated wild-type conidia (Extended 
Data Fig. 4c, d). Moreover, using ELISA, we demonstrated a direct 
interaction of MelLec with purified YWA1 (Fig. 2d). This suggested 
that the ability of MelLec to recognize YWA1, as well as all of the other 
melanin biosynthetic intermediates (Fig. 2c), was due to recognition 
of the conserved naphthalene-diol unit, present in each of the inter-
mediates. Indeed, we revealed a direct interaction of MelLec with 
1,8-dihydronaphthalene (1,8-DHN), another upstream intermedi-
ate of the melanin biosynthetic pathway, by ELISA (Extended Data 
Fig. 4e). The structural isomers 1,2-DHN and 1,4-DHN, which contain 
the naphthalene-diol unit but are not melanin intermediates, were also 
recognized by MelLec (Extended Data Fig. 4f). This suggests that the 
position of at least one of the hydroxyls (on carbon 2, 4 or 8) on the 
naphthalene-diol unit is not important for recognition by MelLec. By 
contrast, naphthalene and 1-naphthol were not recognized by MelLec 
(Extended Data Fig. 4g), indicating that the ligand of MelLec is a 
naphthalene-diol.
CLRs involved in fungal recognition are predominantly expressed 
by myeloid cells and are detectable in most tissues1. Using reverse 
transcription PCR (RT–PCR), we found that MelLec was widely 
expressed in mice, with the highest levels of transcript detected in the 
lung (Extended Data Fig. 5a). To explore expression at a cellular level, 
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Figure 1 | MelLec recognizes selected fungi. a, b, Representative 
histograms showing A. fumigatus conidia and germlings (cultured for 8 h 
at 37 °C) (a) and yeasts of C. albicans and S. cerevisiae, and conidia of  
F. pedrosoi (b) stained with Fc-MelLec or Fc-CLEC12B (ref. 24) (Fc-control) 
and analysed by flow cytometry. c–e, Representative light microscopy 
images and immunofluorescence micrographs using Fc-MelLec to detect 
ligands on A. fumigatus, after conidial swelling and germination over time 
(c), after treatment with 1 M NaOH (d) and on rodlet-deficient (ΔrodA) 
conidia (e). Experiments were repeated at least three times independently, 
with similar results.
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we generated monoclonal antibodies by immunizing rats with murine 
Fc-MelLec and then screening ELISA-positive hybridoma supernatants 
using flow cytometry on NIH3T3 cells transfected to express full-length 
haemagglutinin-tagged murine MelLec. In these transfected cells, we 
found that MelLec was expressed as a glycosylated monomer at the cell 
surface, which demonstrated that this CLR did not require an adaptor 
for surface expression1,14 (Extended Data Fig. 5b, c). Although MelLec 
is able to sense melanin (Fig. 2 and Extended Data Fig. 1f), the expres-
sion of this receptor on these transfected NIH3T3 cells did not confer 
the ability to capture A. fumigatus conidia to the cell surface (Extended 
Data Fig. 5d).
Two monoclonal antibodies (18E4 and 14C8) specific for MelLec 
were chosen for further characterization of receptor expression on 
mouse cells and tissues (Extended Data Fig. 5e). Surprisingly, MelLec 
was not expressed by any examined mouse myeloid cell population 
(either ex vivo or in vitro bone marrow-derived), even after micro-
bial stimulation, nor was this receptor expressed by cells in peripheral 
blood, bone marrow, lymphoid tissues or on platelets15 (Extended 
Data Fig. 6a–c). Given the abundance of transcript, next we examined 
disaggregated lung tissue by flow cytometry, which revealed a dis-
tinct population of cells that expressed MelLec (Fig. 3a). Histological 
visualization of MelLec expression by immunofluorescence microscopy 
revealed broad punctate expression of this receptor throughout the 
lung tissue (Fig. 3b and Extended Data Fig. 7m). A similar punctate 
staining pattern was also observed in the MelLec-expressing trans-
fected NIH3T3 fibroblasts (Extended Data Fig. 7a). Flow cytometry 
analysis showed that MelLec expression was restricted to non-haemato-
poietic (CD45−) cells (Fig. 3c and Extended Data Fig. 7b). Further 
characterization of these cells revealed that MelLec was expressed by 
CD31+ EpCAM− endothelial cells (EpCAM, epithelial cell adhesion 
molecule) (Fig. 3d). Expression of MelLec was also detected on CD31+ 
endothelial cells in all other tissues tested, including the liver, heart, 
kidney and small intestine (Extended Data Fig. 7c–f). However, we 
also detected a unique population of CD31+ cells that co-expressed 
EpCAM+, but only in the lung and the liver, and these cells also 
expressed MelLec (Fig. 3d and Extended Data Fig. 7c). MelLec was not 
expressed on EpCAM+ cells in other tissues, including in the epidermis 
(Extended Data Fig. 7g–j).
To gain insight into the physiological functions of MelLec, we gene-
rated mice deficient in this receptor using a conventional gene-targeting 
vector (Extended Data Fig. 7k, l). Exons 1–5 of the gene encoding 
MelLec (Clec1a) were deleted; these exons correspond to the cyto-
plasmic tail, transmembrane, stalk and part of the CRD region. Flow 
cytometry of disaggregated lung tissue, and immunofluorescence 
microscopy of whole lung, confirmed the lack of MelLec expression 
in cells from knockout mice (Fig. 3b and Extended Data Fig. 7m, n). 
The MelLec-knockout mice were viable, had no gross abnormalities 
and had normal peripheral leucocyte counts (Supplementary Table 2). 
Intratracheal (i.t.) challenge of immunocompetent MelLec-knockout 
mice with wild type A. fumigatus conidia revealed no alterations 
in survival or in other physiological parameters, including weight 
(Extended Data Fig. 8a). However, a significantly reduced influx of 
neutrophils into the lungs of MelLec-knockout mice could be detected 
shortly (4 h) after i.t. challenge (Extended Data Fig. 8b–d), before the 
conidia had germinated16. This alteration in cellular recruitment in 
the MelLec-knockout mice was associated with alterations in selected 
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Figure 2 | MelLec recognizes DHN-melanin. a, Detection of MelLec 
ligands in alkali-insoluble and alkali-soluble A. fumigatus cell-wall 
fractions by ELISA. Values show mean ± s.d. b, Representative histograms 
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c, The biosynthetic pathway of DHN-melanin (left), and representative 
immunofluorescence micrographs obtained using Fc-MelLec to detect 
ligands on A. fumigatus strains deficient in the stated enzymes (right).  
The conidial rodlet layer was removed with 1 M NaOH before staining.  
d, Detection of YWA1 by Fc-MelLec and Fc-control by ELISA. Values 
show mean ± s.d. Experiments were repeated at least three times 
independently, with similar results.
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neutrophil-related cytokines, including KC (CXCL1) and granulo-
cyte macrophage colony-stimulating factor (Extended Data Fig. 8e). 
A similar alteration in neutrophil recruitment was also observed in the 
MelLec-knockout mice after i.t. challenge with melanin ghosts of A. 
fumigatus (Extended Data Fig. 8f). There were no alterations in other 
pulmonary myeloid populations after conidial challenge, and by 24 h 
after the challenge the difference in neutrophil influx was no longer 
apparent (Extended Data Fig. 8g, h). There was also no change in the 
expression of MelLec during infection with A. fumigatus (Extended 
Data Fig. 8i). Notably, the defect in early neutrophil-recruitment in the 
MelLec-knockout mice was lost upon i.t. challenge with ΔpksP conidia, 
which lack melanin (Extended Data Fig. 8j, k).
We next examined the role of MelLec during infections in corti-
costeroid-treated mice, to model the effects of immunosuppression17. 
Under these conditions, loss of MelLec did not significantly alter the 
susceptibility to infection (Extended Data Fig. 9a). However, when 
we intravenously (i.v.) infected immunocompetent MelLec-knockout 
mice with A. fumigatus conidia17, we observed substantially increased 
susceptibility in these mice compared to the wild type (Fig. 4a). This 
increased susceptibility was associated with increased fungal burdens 
in several tissues, including the brain (Fig. 4b and Extended Data 
Fig. 9b–d), as well as alterations in inflammatory responses (Fig. 4c). 
IL-17 responses were unaffected18. Consistent with a role in melanin 
recognition, there was no difference in susceptibility or fungal burden 
between wild-type and MelLec-knockout mice after systemic infection 
with ΔpksP conidia (Fig. 4d and Extended Data Fig. 9e).
Our mouse data suggested that MelLec has a key role in the immu-
nity to disseminated infections with Aspergillus. Therefore, we 
next explored the role of this receptor in humans. MelLec has been 
previously detected in humans on endothelial cells19,20 but also on 
myeloid cells5,18–20, and we found that a human MelLec Fc fusion pro-
tein (Fc-hMelLec) recognizes DHN-melanized conidia (Extended 
Data Fig. 10a). A common missense single nucleotide polymorphism 
(SNP) within the coding region of CLEC1A (rs2306894, global minor 
allele frequency = 0.3295) results in an amino acid change (Gly26Ala) 
in the cytoplasmic tail of human MelLec. Notably, we found a highly 
significant association between this SNP and the risk of aspergillosis in 
stem-cell transplant recipients (Fig. 4e). This increased risk occurred 
when the variant was carried by the donor, but not when it was carried 
by the recipient. This suggests that, in humans, the protective functions 
of MelLec are primarily mediated by myeloid cells. In our mouse model, 
there was no difference in resistance to infection upon adoptive transfer 
of MelLec-deficient bone marrow into irradiated wild-type recipients 
(Extended Data Fig. 10b).
To demonstrate the effect of the SNP in CLEC1A and subsequent 
amino acid substitution in MelLec on the function of myeloid cells, 
we analysed the responses of monocyte-derived macrophages isolated 
from healthy genotyped donors. We found that macrophages from the 
individuals carrying this SNP produced significantly less IL-1β and 
IL-8 after in vitro stimulation with A. fumigatus conidia compared to 
controls (Fig. 4f), whereas there was no difference in response upon 
stimulation with lipopolysaccharide (Extended Data Fig. 10c). We veri fied 
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the inflammatory defect caused by this SNP in peripheral blood 
mononuclear cells isolated from an independent cohort (Extended 
Data Fig. 10d). Moreover, using transduced RAW264.7 macrophages, 
we demonstrated directly that this SNP results in an inflammatory 
defect upon stimulation with melanin-containing conidia (Extended 
Data Fig. 10e).
Melanin is considered a fungal virulence factor, providing protection 
against reactive oxygen species and inhibiting host-cell phagocytosis, 
cytokine production and apoptosis3,10,21. Here we show that fungal 
DHN-melanin is also sensed by the host, through a melanin-sensing 
C-type lectin receptor (MelLec) that has a crucial role in the control of 
systemic A. fumigatus infection in both mice and humans. However, 
the data presented here, as well as early studies in rats18,22, show that the 
cellular expression of this receptor differs between species. Critically, 
we define a polymorphism of this receptor that, when present in donor 
cells, increases the susceptibility of stem-cell transplant recipients to 
disseminated aspergillosis. Our data therefore suggest that identifying 
donors carrying this SNP could help considerably to reduce the inci-
dence of this disease in transplant recipients. It is likely that MelLec will 
have an important role in immunity to other melanized fungi and black 
yeasts23, especially those that cause phaeohyphomycosis, mycetoma 
and chromoblastomycosis.
Online Content Methods, along with any additional Extended Data display items and 
Source Data, are available in the online version of the paper; references unique to 
these sections appear only in the online paper.
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MethOdS
Mice and fungal strains. C57BL/6 and Clec1a−/− mice (8–12 weeks old) were 
obtained from the specific pathogen-free facility at the University of Aberdeen. 
Animal experiments were performed using age-matched female mice and con-
formed to the animal care and welfare protocols approved by the UK Home Office 
(project license 70/8073) in compliance with all relevant local ethical regulations. 
Clec1a−/− mice were generated commercially (TaconicArtemis) by conventional 
gene targeting in C57BL/6 embryonic stem cells, as detailed in Extended Data 
Fig. 7. Sample sizes of at least five animals per group were chosen as this would 
allow the detection of a 25% difference in the mean between experimental and con-
trol groups with a probability of greater than 95% (P < 0.05), assuming a standard 
deviation of around 15% and a minimum power value of 0.8. Mice were randomly 
assigned to experimental or control groups, co-housed, and experiments were 
not blinded.
A. fumigatus isolate 13073 (American Type Culture Collection (ATCC)) and a 
clinical isolate CBS 144-89 (ref. 25) were used as wild-type strains. Melanin mutant 
strains (Δalb1(pksP1), Δayg1, Δabr1, Δabr2, Δarp1 and Δarp2 in the B5233 
wild-type background) were generated previously26. ΔrodA and ΔpksPΔrodA 
deletion mutants were generated as described9,10,25. Wild-type CBS110.46 (ref. 27) 
and CBS386.75 (ref. 27) strains with white conidia were also used, as indicated. 
All strains were maintained on 2% (w/v) malt-agar slants or potato dextrose agar 
in culture flasks; conidia were collected and washed before use. Swollen and/or 
germinating morphotypes were obtained upon incubating conidia in Sabouraud 
liquid culture medium at 37 °C for different time intervals, as indicated.
Fc-MelLec production and immunolabelling. Soluble chimaeric proteins 
containing the stalk and C-type lectin-like domain of mouse and human 
MelLec fused to the mutated Fc portion of human immunoglobulin G1 (IgG1) 
were generated essentially as described previously28. In brief, the relevant por-
tions of the MelLec encoding genes were amplified by PCR (mouse primers, 
GAATTCCTCGAGCTGGAGCTCTCCAGGTAC and AAGCTTTCTA 
CCAGCTGTCTAAT; human primers, GGGATCCACTACTACCAGCTCTCC and 
TGGATATCTGTCACCTTCGCCTAATGTTTC), and cloned into the pSecTag2 
expression vector (Invitrogen Life Technologies) containing the mutated form of 
human IgG1 (ref. 29). Sequenced constructs were transfected into HEK293T cells 
using Fugene 6 (Promega), as per the manufacturer’s instructions. Fusion proteins 
were purified from conditioned supernatants by chromatography on protein A 
Sepharose and dialysed against PBS. Fc-Dectin-1 (ref. 28) and Fc-CLEC12B 
(ref. 24) were generated similarly and used as controls.
For flow cytometry, fungi were incubated in 1–3% (w/v) bovine serum albumin 
(BSA) in PBS and Fc-proteins were added to a final concentration of 5 μg ml−1. 
Following incubation at 4 °C, fungal particles were washed in fluorescence- 
activated cell sorting (FACS) buffer (0.5% (w/v) BSA and 2 mM EDTA in PBS), 
and bound Fc-proteins detected with allophycocyanin (APC) or phycoerythrin 
(PE)-conjugated donkey anti-human antibody (Jackson ImmunoResearch), fixed 
in 1% (v/v) formaldehyde, and analysed.
For microscopy, paraformaldehyde-fixed conidia were taken for immuno-
labelling6. To obtain NaOH-treated conidia, 1 M NaOH was added to conidia 
and heated in a boiling water bath for 1 h, followed by centrifugation to collect 
conidia and extensive washing. Melanin ghosts were isolated from conidia 
(B5233 as well as melanin mutant strains) by harsh chemical treatments that 
degrade other cellular components and result in hollow spherical-shaped melanin 
shells (‘melanin ghosts’), as described previously30. For immunostaining, fungal 
particles were incubated with 5 μg ml−1 Fc-MelLec in PBS containing 1% (w/v) 
BSA for 1 h. After washing, bound Fc-MelLec was detected with fluorescein iso-
thiocyanate (FITC)-labelled goat anti-human Fc-specific IgG (Sigma) in PBS 
containing 1% (w/v) BSA and washed with PBS-Tween. Conidia incubated with 
FITC-labelled anti-human Fc-specific IgG only were used as a negative control 
(data not shown). Labelled conidia were observed by fluorescence microscopy 
(Leica DMLB).
In some experiments, Fc-proteins were pretreated with either ghosts of melanin 
mutant strains, as indicated, or YWA1, which was isolated from AYG1 deletion 
mutant conidia as described previously13.
Monoclonal antibody production. The generation of monoclonal antibodies 
to MelLec was performed essentially as described previously31. In brief, Sprague 
Dawley rats were immunized with Fc-MelLec in Freund’s complete adjuvant. 
After a final intraperitoneal boost, without adjuvant, rat splenocytes were col-
lected and fused with Y3 myeloma cells, as described32. Hybridoma supernatants 
were screened by ELISA and positives were then tested by immunohistochemistry 
and flow cytometry, as described below, against Fc-MelLec as well as MelLec-
transduced NIH3T3 fibroblasts. Two monoclonal antibodies (14C8 and 18E4; both 
IgG1) were selected for further use. Where required, they were biotinylated with 
Sulfo-NHS-LC Biotin (Pierce), as described by the manufacturer.
Cell culture and growth conditions. Cells were maintained at 37 °C and 5% CO2 in 
DMEM or RPMI medium supplemented with 10% heat-inactivated fetal calf serum, 
100 units per ml penicillin, 0.1 mg ml−1 streptomycin, and 2 mM l-glutamine. 
Phoenix ecotropic packaging cells (Plat-E) were maintained with the addition of 
1 μg ml−1 puromycin and 10 μg ml−1 blasticidin (Life Technologies, Inc.).
NIH3T3 fibroblasts stably expressing full-length murine or human MelLec were 
generated essentially as described for Dectin-1 (ref. 33). In brief, haemagglutinin- 
tagged MelLec was generated through PCR amplification (mouse primers, GGA 
TCCACCATGCAGGCCAAATACAGCA and CTCGAGCTACTGGAGCT 
CTCCAGGTAC; human primers, AAAGGATCCACCATGCAGGCCAAGT 
ACAGCAGCAC and AGCGTAATCCGGAACATCGTATGGGTACTCGAG) 
and subcloning into pFb-neo (Stratagene). Constructs were transfected into Plat-E 
retroviral packaging cell lines using Fugene 6 and retrovirus-containing 
supernatants were used to transduce NIH3T3 fibroblasts in the presence of 
polybrene (Sigma). Stably transfected cells were selected using 600 μg ml−1 G418 
(ThermoFisher Inc.). The expression of the receptor was confirmed by flow 
cytometry and western blotting, using the anti-haemagglutinin antibody 
(Covance). In some experiments, NIH3T3 cells expressing murine CLEC12A 
(ref. 31) were used as controls.
ELISA assays. Alkali-insoluble and soluble fungal cell wall fractions were obtained 
as described previously34. For the ELISA, wells were coated overnight with 
20–200 μg ml−1 of the cell wall fractions, melanin ghosts (in-house generated), 
purified YWA1 (in-house generated), 1,8-DHN, 1,2-DHN, 1,4-DHN, naphthalene, 
1-naphthol (all from Sigma) in 50 mM carbonate buffer pH 9.6, and then blocked 
with 1% BSA in PBS. Fc-MelLec (5 μg ml−1) was added to the wells and incubated 
for 1 h at room temperature. After washing with PBS-Tween-20 (0.5% (v/v)), 
peroxidase-conjugated human Fc-specific IgG (Sigma) was added to the wells and 
incubated for 1 h at room temperature. After further washing, quantification of 
Fc-MelLec binding was detected using o-phenylenediamine (Sigma) and H2O2 
detection system (Merck). The reaction was stopped using 4% (v/v) H2SO4 and 
optical densities were measured at 492 nm.
Expression analysis. Peripheral blood leucocytes, resident and thioglycolate- 
elicited inflammatory peritoneal cells, alveolar macrophages and bone marrow 
cells were isolated essentially as described previously35. For platelets, peripheral 
blood was collected in 3.8% (w/v) sodium citrate buffer and centrifuged at 200g at 
25 °C. The supernatant, containing platelet-rich plasma, was used for sub sequent 
analysis. Bone marrow-derived macrophages or dendritic cells, generated using 
L929 conditioned medium or 20 ng ml−1 granulocyte–macrophage colony- 
stimulating factor (R&D Systems), respectively, were prepared as described31. In 
some experiments, cells were stimulated with 100 ng ml−1 lipopolysaccharide from 
Escherichia coli (Sigma).
Tissues isolated from mice were cut into small pieces and incubated for 30 min 
at 37 °C with Liberase (Roche) and DNase (Roche) in RPMI (Gibco), except for the 
small intestine which was incubated with Collagenase VIII (Sigma-Aldrich). Cells 
were disaggregated using the gentleMACS Dissociator (Miltenyi), strained through 
70-μm nylon cell strainers (Fisher Scientific) and collected by centrifugation. Red 
blood cells were removed using Pharm Lyse (BD Biosciences).
For flow cytometry, isolated cells were washed in FACS wash (PBS with 0.5% 
(w/v) BSA and 5–10 mM EDTA) containing anti-CD16/CD32 (Clone 2.4G2, pre-
pared in house). The following antibodies (all from BD Biosciences, eBioscience 
or Abcam) were used for FACS analysis of cell surface antigen expression follow-
ing standard methodology: anti-MelLec-Biotin (described above), Streptavidin-
PE-CF594 or Streptavidin-APC, anti-CD45.2-FITC (clone 104), biotinylated 
anti-CD61 (clone 2C9.G2), anti-CD326-APC (EpCAM; clone G8.8), anti-CD31-
PE-Cyanine7 (PECAM-1; clone 390), anti-Ly6G-APC (clone 1A8), anti-CD11b-
PE-Cy7 (clone M1/70), CD11c-PerCP-Cy5.5 (clone HL3), anti-Siglec-F-BV421 
(clone E50-2440), anti-CD45-PE-Cy7 (clone 30-F11), anti-CD11b-PerCP-Cy5.5 
(clone M1/70), anti-CD11c-BV421 (clone HL3), anti-Siglec-F-PE (clone E50-
2440) and anti-F4/80-AF700 (clone CL:A3-1) and isotype control AFRC MAC 
49 (ECACC 85060404; isotype for anti-MelLec). Cell viability was detected using 
the fixable viability dye eFluor-780 (eBioscience) in PBS, and the cells were fixed 
with 1% formaldehyde (v/v) before acquisition on a LSRII, LSR Fortessa or FACS 
Calibur (Becton Dickinson). Data were analysed using FlowJo. All contour plots 
were constructed using 2% probability contouring with outliers.
For immunofluorescence microscopy, 6 μm alcohol-fixed frozen lung sections 
were treated with Liberase (Roche) for 4 min at room temperature. Sections were 
blocked with 2% (v/v) normal goat serum, and incubated with anti-MelLec or 
isotype control for 1 h followed by AlexaFluor 488 goat anti-rat (Invitrogen) for 
30 min. Vectashield with DAPI or propidium iodide (Vector Laboratories Inc.) was 
used as a mountant for fluorescence, and slides were visualized using a Zeiss LSM 
700 confocal microscope. Visualization of transfected NIH3T3 cells was performed 
similarly, except the cells were fixed in 4% (v/v) paraformaldehyde before analysis.
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Detection of MelLec in complementary DNA (cDNA) (Multiple Tissue 
Panels, Clontech) was performed using the Titanium Taq PCR kit (Clontech) 
with the following primers: CAGAGCCCAGGCACTCAGAGAATG and 
TGCGGGAGAGCCCTGTCCAAT. Expression of G3PDH was detected as 
described previously36.
Mouse infection models. For pulmonary infections, 105 (corticosteroid model) or 
107 A. fumigatus ATCC 13073 conidia were administered to the caudal oropharynx 
of anaesthetized mice. In some experiments, mice were administered with 0.6 mg 
of the corticosteroid, triamcinolone acetonide37 (Bristol-Myers Squibb), on days 
−1, 1 and 3, relative to infection on day 0. For systemic infections, 106 A. fumigatus 
ATCC 13073 conidia were administered to the lateral tail vein of mice. Mice were 
killed when they had lost 30% body weight or had become moribund. Pulmonary 
cellular inflammation was assessed by flow cytometry after total lung enzymatic 
digest, as described above, or in bronchoalveolar lavage samples, isolated with PBS 
containing 5 mM EDTA (Gibco). Organs were homogenized in PBS and used for 
the determination of fungal burdens and levels of inflammatory cytokines. Fungal 
burdens were determined by serial dilution onto potato dextrose agar plates and 
normalized to organ weights. Cytokines were measured by ELISA (R&D DuoSet), 
as described by the manufacturer, and normalized to protein concentration. Bone 
marrow chimaeric mice were generated as described previously38.
Glycan microarray analyses. Microarray analyses were carried out using the 
neoglycolipid-based microarray system39. Details of the glycan probe library, the 
generation of the microarrays, imaging and data analysis are in the supplemen-
tary glycan microarray document (Supplementary Table 3) in accordance with the 
MIRAGE (minimum information required for a glycomics experiment) guidelines 
for reporting glycan microarray-based data. The microarray contained 496 lipid-
linked glycan probes (Supplementary Table 1). Microarray analysis of the soluble 
Fc-MelLec was performed essentially as described8. In brief, after blocking arrayed 
slides with 0.04% (v/v) Blocker Casein (Pierce), 1% (w/v) BSA (Sigma A8577) 
in HEPES-buffered saline (5 mM HEPES, pH 7.4, 150 mM NaCl, 5 mM CaCl2), 
mouse Fc-MelLec was precomplexed with biotinylated anti-human IgG (Vector) at 
a 1:3 ratio (w/w) before application onto the slides at a final concentration of 10 μg 
ml−1. Flag-tagged human langerin was included as a positive control. The protein 
and rat anti-Flag antibody mAb L5 were provided by C. G. Park. For analysis, 
the Flag-tagged langerin was precomplexed with the rat anti-Flag at a 1:3 ratio 
(w/w) and applied onto the slides at a final concentration of 5 μg ml−1, followed by 
biotinylated anti-rat IgG (Pierce) (5 μg ml−1). To detect binding, AlexaFluor-647-
labelled streptavidin from Molecular Probes was used at 1 μg ml−1. Data analysis 
and presentation was performed with dedicated glycan microarray software40.
Human studies. A total of 310 haematologic patients undergoing allogeneic 
haematopoietic stem cell transplantation at the Hospital of Santa Maria, Lisbon 
and Instituto Português de Oncologia (IPO), Porto, between 2009 and 2014 were 
enrolled in the study. The cases of invasive aspergillosis were identified and clas-
sified as ‘probable’ or ‘proven’ according to the revised standard criteria from the 
European Organization for Research and Treatment of Cancer/Mycology Study 
Group (EORTC/MSG)41. Exclusion criteria included diagnosis of ‘possible’ inva-
sive aspergillosis, infection with invasive moulds other than Aspergillus spp. or 
history of pre-transplant mould infection. Study approval was obtained from the 
institutional review boards (SECVS-125/2014, HSM-632/14 and CES.26/015) and 
from the National Data Protection Commission (CNPD, 1950/2015) and was in 
compliance with all local relevant ethical regulations.
Genomic DNA was isolated from whole blood of recipients and donors (before 
transplantation) using the QIAcube automated system (Qiagen) at the regional cen-
tres of the Instituto Português do Sangue e Transplantação (Portugal). Genotyping 
of the nonsynonymous rs2306894 SNP in the CLEC1A gene was performed using 
KASPar assays (LGC Genomics) according to the manufacturer’s instructions in an 
Applied Biosystems 7500 Fast real-time PCR system (Thermo Fisher). Genotyping 
sets included randomly selected replicates of previously typed samples, and agree-
ment between original and duplicate samples was ≥ 99%.
Peripheral blood mononuclear cells from healthy genotyped donors were 
enriched from buffy coats using Histopaque-1077 (Sigma-Aldrich) and contami-
nating erythrocytes were removed using Red Blood Cell Lysis Buffer (Sigma-
Aldrich). Participants gave written informed consent before blood collection. 
Monocytes were isolated by positive selection using magnetically labelled CD14+ 
MicroBeads (Miltenyi Biotec) on a MiniMACS separator and seeded at 106 cells 
per ml in 24-well plates for 7 days in RPMI-1640 medium supplemented with 
10% (v/v) human serum and 20 ng ml−1 recombinant human granulocyte macro-
phage colony-stimulating factor (GM-CSF, Gibco). Acquisition of macrophage 
morphology was confirmed by phase contrast microscopy (Axiovert 135, Zeiss). 
For infection, macrophages were washed and then infected with live conidia of 
A. fumigatus strain A1163 at a ratio of 1:10 (cells:fungus) for 20 h at 37 °C and 
5% CO2. Cytokines in supernatants were detected using DuoSet ELISA systems 
(BioLegend), according to the manufacturer’s instructions. At least two technical 
replicates were performed for each donor.
For the independent cohort, genomic DNA was isolated from EDTA venous 
blood of healthy Dutch volunteers using the Gentra Pure Gene Blood kit (Qiagen) 
and genotyped for CLEC1A polymorphisms using the Illumina Immunochip SNP 
array platform, described previously42. Participants gave written informed consent 
before blood collection. As the CLEC1A SNP of interest (exonic rs2306894) was not 
represented on the genotyping platform, two intronic polymorphisms (rs7972187 
and rs3825300) were used as markers. Linkage analysis revealed complete linkage 
disequilibrium of these two polymorphisms with the SNP of interest43 (R2 = 1). A 
total of 105 peripheral blood mononuclear cells isolated from genotyped donors 
were stimulated with 107 killed conidia per ml of the clinical isolate A. fumigatus 
V05-27 (ref. 44). After 24-h incubation in the presence of 10% human pooled 
serum at 37 °C and 5% CO2, supernatants were collected and IL-1β and IL-8 were 
measured by ELISA (R&D Systems and PeliKine, respectively).
Statistical analysis. The probability of invasive aspergillosis resulting from 
CLEC1A rs2306894 SNP was analysed using the cumulative incidence method 
and compared using Gray’s test45. Cumulative incidences were computed with the 
cmprsk package for R version 2.10.1 (ref. 46), with censoring of data at the date of 
last follow-up visit and defining relapse and death as competing events. A period 
of 24 months after transplant was chosen to include all cases of fungal infection. 
Mouse survival data were analysed with the log rank test using GraphPad Prism. 
No data was excluded.
In vitro and ex vivo data were analysed using the GraphPad Prism software. 
Two-tailed student’s t-tests or Mann–Whitney U tests were used to determine 
statistical significance. All experiments were independently repeated at least once, 
unless otherwise indicated. 
Data availability. The data that support the findings of this study are available 
from the corresponding author upon reasonable request.
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Extended Data Figure 1 | MelLec recognizes ligands on selected 
fungi and fungal morphotypes. a, b, Cartoon representations of the 
structures of Fc-MelLec (a) and the full-length receptor (b). Lollipop 
structures represent predicted glycosylation sites. c, Fc-MelLec or Fc-
CLEC12B (Fc-control) staining of C. albicans hyphae, generated in 
RPMI with 10% fetal bovine serum for 90 min. Fungal particles were 
analysed by flow cytometry. Experiment was repeated independently 
twice, with similar results. d, Representative light microscopy images 
and immunofluorescence micrographs using Fc-MelLec or anti-
galactomannan (GM, control) as probes to detect ligands on A. fumigatus 
mycelium. Experiments were repeated three times independently, 
with similar results. e, Representative light microscopy images and 
immunofluorescence micrographs showing the surface distribution 
of MelLec ligands on C. cladosporioides using Fc-MelLec as a probe. 
The lower panels show fungal cells after treatment with 1 M NaOH. 
Experiments were repeated three times independently, with similar  
results. f, IL-2 production by MelLec-expressing BWZ reporter cells  
after stimulation by anti-MelLec antibody (αMelLec) crosslinking or with 
ΔrodA (1:1, 5:1, 10:1) or ΔrodAΔpksP (5:1, 10:1) A. fumigatus conidia, as 
indicated. Values shown are mean ± s.d. Experiment was repeated three 
times independently, with similar results.
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Extended Data Figure 2 | Glycan microarray analyses of mouse Fc-MelLec  
and human langerin. These 496 lipid-linked probes are arranged 
according to their backbone sequences as annotated in the coloured panels 
below the figure. GAGs, glycosaminoglycans; Lac, lactose; LacNAc,  
N-acetyllactosamine; LNnT, lacto-N-neotetraose; LNT, lacto-N-tetraose; 
Misc., miscellaneous; PolyLac, polylactosamine. The signals are means 
of fluorescence intensities of duplicate spots, printed at 5 fM per spot 
level with error bars representing half of the difference between the 
two values. The signals shown together with the probe sequences are in 
Supplementary Table 1. NS, not significant.
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Extended Data Figure 3 | MelLec recognizes DHN-melanin. 
a, Representative immunofluorescence micrographs using Fc-MelLec as 
a probe showing the surface distribution of MelLec-ligands on wild-type 
A. fumigatus and various melanin-deficient mutants. Lower panels show 
conidia treated with 1 M NaOH. b, Representative immunofluorescence 
micrographs and light microscopy images of ΔrodAΔpksP A. fumigatus 
conidia stained with Fc-MelLec or ConA-FITC. c, Representative 
histograms showing the presence or absence of MelLec or Dectin-1 
ligands on ΔrodA or ΔrodAΔpksP A. fumigatus conidia. Fungal particles 
were stained with Fc-MelLec (red) or Fc-Dectin-1 (green) and analysed 
by flow cytometry. Grey histograms indicate secondary-only control. 
d, Representative histogram showing the presence of Dectin-1 ligands  
on ΔpksP A. fumigatus conidia. Fungal particles were stained with  
Fc-Dectin-1 (green) or Fc-CLEC12B (Fc-control; blue) and analysed by 
flow cytometry. e, Representative histogram showing the presence of 
MelLec ligands on melanin ghosts of A. fumigatus conidia. Fungal particles 
were stained with Fc-MelLec (red) or Fc-CLEC12B (Fc-control; blue) 
and analysed by flow cytometry. In a–e, experiments were repeated three 
times independently, with similar results. f, Flow-cytometric analysis of 
melanized (red) and non-melanized (grey) Cryptococcus neoformans yeast 
and melanin ghosts, and B16 melanoma cells47, stained with Fc-MelLec. 
The experiment was repeated independently twice, with similar results.
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Extended Data Figure 4 | MelLec recognizes naphthalene-diol. 
a, Detection of MelLec ligands in ghosts of melanin mutants of 
A. fumigatus by ELISA, as indicated. Values show mean ± s.d. 
b, Representative immunofluorescence and light micrograph images 
of Fc-MelLec ligands on NaOH-treated A. fumigatus B5233 conidia 
after pretreatment with ghosts of ΔpksP or Δayg1 conidia, as indicated. 
c, Representative immunofluorescence micrographs and light microscopy 
images of MelLec ligands on NaOH-treated wild-type A. fumigatus conidia 
after pretreatment with or without YWA1. In a–c, experiments were 
repeated at least three times independently, with similar results.  
d, Detection of Fc-MelLec or Fc-Dectin-1 ligands on ΔrodA conidia  
after pretreatment with (blue) or without (red) YWA1. The experiment  
was repeated independently twice, with similar results. e, f, Detection  
of 1,8-DHN (e) and 1,2-DHN and 1,4-DHN (f) by Fc-MelLec and  
Fc-control using ELISA. Values show mean ± s.d. g, Detection of  
1,8-DHN, naphthalene and 1-naphthol by Fc-MelLec using ELISA. Values 
show mean ± s.d. In e–g, experiments were repeated at least three times 
independently, with similar results.
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Extended Data Figure 5 | MelLec is expressed at the cell surface.  
a, RT–PCR detection of MelLec expression in various tissues. The 
expression of glyceraldehyde-3-phosphate dehydrogenase (G3PDH) in 
these samples, also used for the characterization of MCL36, is shown as 
a control. The experiment was performed once; for gel source data, see 
Supplementary Fig. 1. b, Flow-cytometric analysis of surface expression of 
haemagglutinin-tagged mouse (m) and human (h) MelLec on the surface 
of NIH3T3 fibroblasts (black open histograms). NIH3T3 cells transfected 
with vector only served as controls (grey filled histograms). c, Western-
blot analysis of lysates of haemagglutinin-tagged MelLec expressing 
NIH3T3 cells under reducing and non-reducing conditions and with 
(+) and without (−) N-glycosidase. Haemagglutinin-tagged CLEC12A 
(ref. 31) expressing NIH3T3 cells served as controls (for blot source data, 
see Supplementary Fig. 1). d, Relative binding of FITC-labelled ΔrodA 
A. fumigatus conidia to NIH3T3 cells transduced with vector only, 
Dectin-1 or MelLec, as determined by flow cytometry. Values shown are 
mean ± s.d., analysed by one-way ANOVA. e, Screening of hybridoma 
supernatants on MelLec-expressing (red) and parental (black) NIH3T3 
cells. In b–e, experiments were repeated at least three times independently, 
with similar results. *P ≤ 0.05; NS, not significant.
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Extended Data Figure 6 | Mouse MelLec is not expressed by myeloid 
cells. a, b, Flow-cytometric analysis of MelLec expression on various 
ex vivo and in vitro derived myeloid cells (a) and peripheral blood, bone 
marrow, lymph nodes and spleen (b). Experiments were repeated at least 
twice independently, with similar results. c, Flow-cytometric analysis of 
MelLec expression on CD61+ platelets. Experiment was repeated at least 
three times independently, with similar results. BM, bone marrow; DC, 
dendritic cell; LPS, lipopolysaccharide; mø, macrophage.
© 2018 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
LetterreSeArCH
Extended Data Figure 7 | See next page for caption.
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Extended Data Figure 7 | MelLec expression in tissues and generation 
of Clec1a−/− mice. a, Immunofluorescence microscopy of MelLec-
expressing versus control NIH3T3 cells labelled with anti-MelLec antibody 
(green). Nuclei are stained with DAPI (blue). Experiments were repeated 
at least three times independently, with similar results. b, Exemplar flow-
cytometric gating strategy for identification of live cells from tissue. c, 
Flow-cytometric analysis of MelLec expression on live CD45−CD31+ 
EpCAM− and EpCAM+ populations in the liver. d–j, Flow cytometric 
analysis of MelLec expression on live CD45−CD31+ cells in the heart 
(d), kidney (e) and small intestine (f), and on live CD45−EpCAM+ cells 
in the heart (g), kidney (h), small intestine (i) and epidermis (j). In b–j, 
experiments were repeated at least twice independently, with similar 
results. Black lines, isotype controls. k, Schematic of the wild-type Clec1a 
locus, gene targeting vector, PCR primer sites and correctly targeted 
recombinant allele. l, PCR analysis of gene-targeted mice (for gel source 
data, see Supplementary Fig. 1). +/+, wild-type, +/− heterozygous 
and −/− homozygous for the targeted allele. m, Immunofluorescence 
microscopy of naive lung tissue from Clec1a−/− mice (labelling of 
wild-type lung is shown in Fig. 3b). n, Analysis of MelLec expression 
in disaggregated lung tissue from wild-type (wt) or Clec1a−/− mice by 
flow cytometry. In l–n, experiments were repeated at least three times 
independently, with similar results.
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Extended Data Figure 8 | See next page for caption.
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Extended Data Figure 8 | Clec1a−/− mice show early inflammatory 
defects upon challenge with A. fumigatus. a, Survival (left) and weight 
measurements (right) of immunocompetent mice after i.t. infection 
with 107 A. fumigatus conidia (n = 4 mice per group). Values shown 
are mean ± s.d. b, Exemplar flow-cytometric gating strategy for the 
identification of CD45+ cells from bronchoalveolar lavage.  
c, Representative FACS profiles of pulmonary CD11b+ Ly6Ghigh 
neutrophils in wild-type and Clec1a−/− mice 4 h after challenge with  
107 A. fumigatus conidia (wild-type n = 29 mice; Clec1a−/− n = 26 mice). 
d, e, Pulmonary CD11b+ Ly6Ghigh neutrophils (wild-type n = 29 mice, 
Clec1a−/− n = 26 mice) (d) and cytokines (n = 25 mice per group) (e) 
in mice 4 h after challenge with 107 A. fumigatus conidia. f, Pulmonary 
CD11b+ Ly6Ghigh neutrophils in mice 4 h after challenge with melanin 
ghosts (160 μg) of A. fumigatus (wild-type n = 15 mice; Clec1a−/− n = 10 
mice). Samples with blood contamination were excluded. g, Pulmonary 
CD11b+ Ly6Ghigh neutrophils in mice 24 h after challenge with  
107 A. fumigatus conidia (wild-type n = 33 mice, Clec1a−/− n = 30 mice). 
h, Cellular inflammatory profiles of mice 24 h after challenge with  
107 A. fumigatus conidia (wild-type n = 33 mice, Clec1a−/− n = 30 mice). 
Alveolar macrophages were defined as CD11c+Siglec-F+, inflammatory 
macrophages as CD11b+ F4/80+ and eosinophils as CD11b+Siglec-F+. 
In d–h, values shown are mean ± s.e.m. of pooled data from at least two 
independent experiments, analysed by two-sided Mann–Whitney U  
test. i, Expression of MelLec on pulmonary CD45− CD31+ cells isolated 
from uninfected mice (black) and mice 24 h after infection with  
A. fumigatus conidia (red). Grey line, isotype control (n = 3 mice per 
group). j, Pulmonary CD11b+ Ly6Ghigh neutrophils in mice 4 h after 
challenge with 107 ΔpksP A. fumigatus conidia (wild-type n = 7 mice, 
Clec1a−/− n = 8 mice). Values shown are mean ± s.e.m. of pooled data 
from two independent experiments, analysed by two-sided Mann–
Whitney U test. k, Representative FACS profiles of pulmonary CD11b+ 
Ly6Ghigh neutrophils in wild-type and Clec1a−/− mice 4 h after challenge 
with 107 ΔpksP A. fumigatus conidia (wild-type n = 7 mice, Clec1a−/− 
n = 8 mice). *P ≤ 0.05; NS, not significant.
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Extended Data Figure 9 | Clec1a−/− mice show alterations in antifungal 
immunity during systemic infection. a, Survival of corticosteroid-treated 
mice after i.t. infection with 105 A. fumigatus conidia (n = 15 mice per 
group). Pooled data from two independent experiments, analysed by log-
rank test. b, Fungal burdens in various mouse tissues, as indicated, 4 days 
after i.v. infection with 106 A. fumigatus conidia (n = 12 mice per group). 
Values shown are mean ± s.e.m. of pooled data from two independent 
experiments, analysed by two-sided Mann–Whitney U test. c, Tissue 
section of kidney from day-4-infected Clec1a−/− mouse stained with 
Grocott’s methenamine silver stain and haematoxylin (n = 3 mice per 
group). d, Immunofluorescence microscopy of brain from day-2-infected 
Clec1a−/− mouse (n = 3 mice per group). Fungi are stained with calcofluor 
white (blue), leukocytes with Gr1 (green) and DNA with propidium iodide 
(red). e, Fungal burdens in various mouse tissues, as indicated, four days 
after i.v. infection with 106 ΔpksP A. fumigatus conidia (n = 4 mice per 
group). Values shown are mean ± s.d., analysed by two-sided Mann–
Whitney U test. *P ≤ 0.05; NS, not significant.
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Extended Data Figure 10 | A single nucleotide polymorphism in 
human MelLec influences anti-Aspergillus inflammatory responses. 
a, Representative histograms showing the presence or absence of 
human MelLec ligands on ΔrodA or ΔrodAΔpksP A. fumigatus 
conidia, as determined by flow cytometry. Fc-CLEC12B was used as a 
control (Fc-control). The experiment was repeated at least three times 
independently, with similar results. b, Survival of irradiated wild-type 
mice reconstituted with wild-type or Clec1a−/− bone marrow (BM), 
as indicated, after i.v. infection with 106 A. fumigatus conidia (n = 16 
mice per group). Pooled data from two independent experiments, 
analysed by log-rank test. c, Inflammatory cytokine production in 
monocyte-derived macrophages isolated from genotyped individuals, 
after stimulation with lipopolysaccharide (wild-type n = 14 individuals, 
SNP allele n = 5 individuals). Values shown are mean ± s.d., analysed by 
two-sided Mann–Whitney U test. d, Inflammatory cytokine production 
in peripheral blood mononuclear cells isolated from genotyped Dutch 
individuals, after stimulation with heat-killed A. fumigatus conidia 
(wild-type n = 72 individuals, SNP allele n = 17 individuals). Boxes 
represent the median values and interquartile ranges; whiskers represent 
minimum and maximum values, analysed by two-sided Mann–Whitney 
U test. e, Inflammatory cytokine production in transduced RAW264.7 
macrophages expressing wild-type or SNP allele after stimulation with 
ΔrodA or ΔrodAΔpksP A. fumigatus conidia, as indicated. Values shown 
are mean ± s.d., analysed by one-way ANOVA and repeated at least three 
times independently, with similar results. *P ≤ 0.05; NS, not significant.
© 2018 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
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?    Experimental design
1.   Sample size
Describe how sample size was determined. Sample sizes of at least five per group were chosen as this would allow the 
detection of a 25% difference in the mean between experimental and control 
groups with a probability of greater than 95% (p < 0.05), assuming a standard 
deviation of around 15% and a minimum power value of 0.8. 
2.   Data exclusions
Describe any data exclusions. There were no data exclusions except for data shown in Extended figure 10c, 
where samples with blood contamination were excluded. This is indicated in the 
manuscript. 
3.   Replication
Describe whether the experimental findings were 
reliably reproduced.
All experiments were independently replicated at least once. 
4.   Randomization
Describe how samples/organisms/participants were 
allocated into experimental groups.
Mice were randomly assigned to experimental or control groups, co-housed, and 
experiments were not blinded.
5.   Blinding
Describe whether the investigators were blinded to 
group allocation during data collection and/or analysis.
Mice were randomly assigned to experimental or control groups, co-housed, and 
experiments were not blinded.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
6.   Statistical parameters 
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the 
Methods section if additional space is needed). 
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same 
sample was measured repeatedly
A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one- or two-sided (note: only common tests should be described solely by name; more 
complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted
A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
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?   Software
Policy information about availability of computer code
7. Software
Describe the software used to analyze the data in this 
study.
GraphPad Prism, R version 2.10.1 and ScanArray Express software.
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made 
available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for 
providing algorithms and software for publication provides further information on this topic.
?   Materials and reagents
Policy information about availability of materials
8. Materials availability
Indicate whether there are restrictions on availability of
unique materials or if these materials are only available
for distribution by a for-profit company.
no restrictions
9. Antibodies
Describe the antibodies used and how they were validated
for use in the system under study (i.e. assay and species).
Streptavidin-PE-CF594, anti-CD45.2-FITC (Clone 104), biotinylated anti-CD61 (clone 
2C9.G2), anti-CD326-APC (EpCAM; Clone G8.8), anti-CD31-PE-Cyanine7 (PECAM-1; 
Clone 390), Ly6G-APC (clone 1A8), CD11b-PE-Cy7 (clone M1/70), CD11c-PerCP-
Cy5.5 (clone HL3), Siglec-F-BV421 (clone E50-2440) and F4/80-AF700 (clone 
CL:A3-1) and isotype control AFRC MAC 49 (ECACC 85060404;  isotype for anti-
MelLec). All were purchased commercially from all from BD Biosciences, 
eBioscience or Abcam.  
Anti-MelLec antibodies were generated and validated as follows. Sprague Dawley 
rats were immunised with Fc-MelLec in Freund’s complete adjuvant. After a final 
intraperitoneal boost, without adjuvant, rat splenocytes were harvested and fused 
with Y3 myeloma cells, as described. Hybridoma supernatants were screened by 
ELISA and positives were then tested by immunohistochemistry and flow 
cytometry, as described below, against Fc-MelLec as well as MelLec transduced 
NIH3T3 fibroblasts.   
10. Eukaryotic cell lines
a. State the source of each eukaryotic cell line used. 293T, NIH3T3, RAW265.7 cell lines were originally purchased from the ATTC
b. Describe the method of cell line authentication used. No authentication methods were used. 
c. Report whether the cell lines were tested for
mycoplasma contamination.
Mycoplasma tests were done historically on these cell lines, but not for the 
experiments detailed in the manuscript. 
d. If any of the cell lines used are listed in the database
of commonly misidentified cell lines maintained by
ICLAC, provide a scientific rationale for their use.
none are listed as misidentified
?    Animals and human research participants
Policy information about studies involving animals; when reporting animal research, follow the ARRIVE guidelines
11. Description of research animals
Provide details on animals and/or animal-derived
materials used in the study.
C57BL/6 and Clec1a -/- mice (8-12 weeks old) were obtained from the specific 
pathogen-free facility at the University of Aberdeen. Animal experiments were 
performed using age-matched female mice and conformed to the animal care and 
welfare protocols approved by UK Home Office (project license 70/8073) in 
compliance with all relevant local ethical regulations. Clec1a -/- mice were 
generated commercially (TaconicArtemis) by conventional gene targeting in 
C57BL/6 embryonic stem cells as detailed in Extended data Fig. 7. 
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12. Description of human research participants
Describe the covariate-relevant population 
characteristics of the human research participants.
A total of 310 hematologic patients undergoing allogeneic hematopoietic stem cell 
transplantation at the Hospital of Santa Maria, Lisbon and Instituto Português de 
Oncologia (IPO), Porto, between 2009 and 2014 were enrolled in the study. The 
cases of invasive aspergillosis were identified and classified as “probable” or 
“proven” according to the revised standard criteria from the European 
Organization for Research and Treatment of Cancer/Mycology Study Group 
(EORTC/MSG)41. Exclusion criteria included diagnosis of “possible” invasive 
aspergillosis, infection with invasive moulds other than Aspergillus spp. or history 
of pre-transplant mould infection. Study approval was obtained from the 
institutional review boards (SECVS-125/2014, HSM-632/14 and CES.26/015) and 
from the National Data Protection Commission (CNPD, 1950/2015) and was in 
compliance with all local relevant ethical regulations. 
 Genomic DNA was isolated from whole blood of recipients and donors (before 
transplantation) using the QIAcube automated system (Qiagen) at the regional 
centres of the Instituto Português do Sangue e Transplantação (Portugal). 
Genotyping of the nonsynonymous rs2306894 SNP in the CLEC1A gene was 
performed using KASPar assays (LGC Genomics) according to manufacturer’s 
instructions in an Applied Biosystems 7500 Fast real–time PCR system (Thermo 
Fisher). Genotyping sets included randomly selected replicates of previously typed 
samples, and agreement between original and duplicate samples was ≥99%. 
 Peripheral blood mononuclear cells from healthy genotyped donors were enriched 
from buffy coats using Histopaque®-1077 (Sigma-Aldrich) and contaminating 
erythrocytes removed using Red Blood Cell Lysis Buffer (Sigma-Aldrich). 
Participants gave written informed consent prior to blood collection. Monocytes 
were isolated by positive selection using magnetically labelled CD14+ MicroBeads 
(Miltenyi Biotec) on a MiniMACS separator and seeded at 106 cells/mL in 24-well 
plates for 7 days in RPMI-1640 medium supplemented with 10% (v/v) human 
serum and 20 ng/mL recombinant human granulocyte macrophage colony-
stimulating factor (GM-CSF, Gibco). Acquisition of macrophage morphology was 
confirmed by phase contrast microscopy (Axiovert 135, Zeiss). For infection, 
macrophages were washed and then infected with live conidia of A. fumigatus 
strain A1163 at a ratio of 1:10 (cells/fungus) for 20 h at 37°C and 5% CO2. 
Cytokines in supernatants were detected using DuoSet ELISA systems (BioLegend), 
according to the manufacturer’s instructions. At least two technical replicates were 
performed for each donor. 
 For the independent cohort, genomic DNA was isolated from EDTA venous blood 
of healthy Dutch volunteers using the Gentra Pure Gene Blood kit (Qiagen, Venlo, 
The Netherlands) and genotyped for CLEC1A polymorphisms using the Illumina 
Immunochip SNP array platform, described previously42. Participants gave written 
informed consent prior to blood collection. As the CLEC1A SNP of interest (exonic 
rs2306894) was not represented on the genotyping platform, two intronic 
polymorphisms (rs7972187 and rs3825300) were used as markers. Linkage analysis 
revealed complete linkage disequilibrium of these two polymorphisms with the 
SNP of interest43 (R2=1). 105 PBMCs isolated from genotyped donors were 
stimulated with 107 killed conidia/mL of the clinical isolate A. fumigatus V05-2744. 
After 24 h incubation in the presence of 10% human pooled serum at 37°C and 5% 
CO2 supernatants were collected and IL-1β and IL-8 were measured by ELISA (R&D 
Systems, UK, and PeliKine, Sanquin, The Netherlands, respectively). 
The probability of invasive aspergillosis resulting from CLEC1A rs2306894 SNP was 
analysed using the cumulative incidence method and compared using Gray's 
test45. Cumulative incidences were computed with the cmprsk package for R 
version 2.10.146, with censoring of data at the date of last follow–up visit and 
defining relapse and death as competing events. A period of 24 months after 
transplant was chosen to include all cases of fungal infection. Murine survival data 
were analysed with the log rank test using GraphPad Prism. No data was excluded. 
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?    Data presentation
For all flow cytometry data, confirm that:
1.  The axis labels state the marker and fluorochrome used (e.g. CD4-FITC).
2.  The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of 
identical markers).
3.  All plots are contour plots with outliers or pseudocolor plots.
4.  A numerical value for number of cells or percentage (with statistics) is provided.
?    Methodological details
5.   Describe the sample preparation. Murine cells and tissues 
 
Murine peripheral blood leucocytes, resident and thioglycolate-elicited 
inflammatory peritoneal cells, alveolar macrophages and bone marrow cells were 
isolated essentially as described previously (Taylor PR, Eur J Immunol, 2003). For 
platelets, peripheral blood was collected in 3.8% (w/v) sodium citrate buffer and 
centrifuged at 200xg at 25°C. The supernatant, containing platelet rich plasma, was 
used for subsequent analysis. Bone marrow-derived macrophages or dendritic 
cells, generated using L929 conditioned medium or 20 ng/mL GM-CSF (R&D 
Systems), respectively, were prepared as described (Pyz E, Eur J Immunol, 2008). In 
some experiments, cells were stimulated with 100 ng/mL lipopolysaccharide from 
Escherichia coli (Sigma). 
 
Tissues isolated from mice were cut into small pieces and incubated for 30 min at 
37°C with Liberase (Roche) and DNAse (Roche) in RPMI (Gibco), except for the 
small intestine which was incubated with Collagenase VIII (Sigma-Aldrich). Cells 
were disaggregated using the gentleMACS™ Dissociator (Miltenyi), strained 
through 70 μm nylon cell strainers (Fisher Scientific) and collected by 
centrifugation. Red blood cells were removed using Pharm Lyse (BD Biosciences). 
 
NIH3T3 fibroblasts stably expressing full length murine or human MelLec were  
maintained at 37°C and 5% CO2 in DMEM or RPMI medium supplemented with 
10% heat-inactivated foetal calf serum, 100 units/mL penicillin, 0.1 mg/mL 
streptomycin, and 2 mM L-glutamine. 
 
For flow cytometry, isolated cells were washed in FACS wash (PBS with 0.5% (w/v) 
BSA and 5-10 mM EDTA) containing anti-CD16/CD32 (Clone 2.4G2, prepared in 
house). The following antibodies (all from BD Biosciences, eBioscience or Abcam) 
were used for FACS analysis following standard methodology: anti-MelLec-Biotin, 
Streptavidin-PE-CF594, anti-CD45.2-FITC (Clone 104), biotinylated anti-CD61 (clone 
2C9.G2), anti-CD326-APC (EpCAM; Clone G8.8), anti-CD31-PE-Cyanine7 (PECAM-1; 
Clone 390), Ly6G-APC (clone 1A8), CD11b-PE-Cy7 (clone M1/70), CD11c-PerCP-
Cy5.5 (clone HL3), Siglec-F-BV421 (clone E50-2440) and F4/80-AF700 (clone 
CL:A3-1) and relevant isotype controls. Cell viability was detected using the fixable 
viability dye eFluor-780 (eBioscience) in PBS, and the cells were fixed with 1% 
formaldehyde prior to acquisition. 
 
Fungal strains 
 
For flow cytometry, fungi were incubated in 3% (w/v) BSA in PBS and Fc-proteins 
were added to a final concentration of 5 μg/mL. Following incubation at 4°C, fungal 
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particles were washed in FACS buffer (0.5% (w/v) BSA and 2 mM EDTA in PBS), and 
bound Fc-proteins detected with phycoerythrin-conjugated donkey anti-human 
antibody (Jackson ImmunoResearch), fixed in 1% (v/v) formaldehyde, and analysed. 
6.   Identify the instrument used for data collection. Becton Dickinson LSRII, LSR Fortessa or FACS Calibur cell analyzer.
7.   Describe the software used to collect and analyze 
the flow cytometry data.
For collection Becton Dickinson FACSDiva software was used. For analysis FlowJo 
software was used. 
8.   Describe the abundance of the relevant cell 
populations within post-sort fractions.
No cell populations were sorted for this manuscript.
9.   Describe the gating strategy used. Gating strategy for fungal staining 
Using the FSC/SSC plot, a gate was drawn to select fungal cells and to exclude 
debris. Using SSC/PE plot histogram overlays were made of Fc-MelLec vs Fc-control 
for various fungi. 
 
Gating strategy for murine tissue staining 
Using the FSC/SSC plot, a gate was drawn to select cells and exclude debris. 
Using the SSC/Efluor780 plot, a gate was drawn to select viable cells.  
Using the SSC/FITC plot, we gated on CD45 negative and positive cells.  
In the CD45- population, we gated on CD31 negative or positive cells as well as 
EpCAM negative and positive cells. All subpopulations were assessed for presence 
of MelLec by histogram overlay of the SSC/PECF594 plot for anti-MelLec or isotype. 
 
Gating strategy for BAL  
Using the FSC/SSC plot, a gate was drawn to select cells and exclude debris. 
Using the SSC/CD45FITC plot, we gated on CD45 positive cells.  
In the CD45 positive population, neutrophils (CD11b+Ly6G+), alveolar 
macrophages (CD11c+SiglecF+), inflammatory macrophages (CD11b+F480+) and 
eosinophils (CD11b+SiglecF+) were determined. 
 
Gating strategy for NIH cells 
Using the FSC/SSC plot, a gate was drawn to select NIH cells and to exclude debris. 
Using SSC/PE-CF594 plot histogram overlays were made of anti-MelLec staining on 
NIH-MelLec vs NIH parental cells.  
 
Positive and negative populations for gating were defined using FMO and isotype 
controls. 
 Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
